NXT GEN MED

Serial Number 90634161
Registration 6950936
700

Registration Progress

Application Filed
Apr 9, 2021
Under Examination
Sep 13, 2022
Approved for Publication
Jul 19, 2022
Published for Opposition
Jul 19, 2022
Registered
Jan 10, 2023

Trademark Image

NXT GEN MED

Basic Information

Serial Number
90634161
Registration Number
6950936
Filing Date
April 9, 2021
Registration Date
January 10, 2023
Published for Opposition
July 19, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 10, 2023
Registration
Registered
Classes
041

Rights Holder

Regents of the University of Minnesota

03
Address
600 McNamara Alumni Center
200 Oak St. SE
Minneapolis, MN 55455

Ownership History

Regents of the University of Minnesota

Original Applicant
03
Minneapolis, MN

Regents of the University of Minnesota

Owner at Publication
03
Minneapolis, MN

Regents of the University of Minnesota

Original Registrant
03
Minneapolis, MN

Legal Representation

Attorney
Elizabeth A. Lim

USPTO Deadlines

Next Deadline
1273 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-10)
Due Date
January 10, 2029
Grace Period Ends
July 10, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Jan 10, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 10, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 3, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 2, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 7, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 7, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 21, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 21, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 11, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 11, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 11, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 19, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 19, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 29, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 14, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 17, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 16, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 16, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 11, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 11, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 11, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 8, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 8, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 7, 2022 ALIE A ASSIGNED TO LIE Loading...
Apr 5, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 6, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 6, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 6, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 15, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 16, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 13, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 041
Educational services, namely, providing academic instruction and mentoring in the field of health care that includes technology-enhanced learning experience presenting students with interdisciplinary challenges that require subject matter knowledge, creative problem solving and data analysis
First Use Anywhere: Sep 9, 2022
First Use in Commerce: Sep 9, 2022

Additional Information

Pseudo Mark
NEXT GENERATION MEDICAL

Classification

International Classes
041

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MED"